
ONAPGO (Apomorphine hydrochloride)
4.9 mg/mL · Injection Solution
By MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc
- NDC
- 27505-006
- Route
- Subcutaneous
- Therapeutic class
- Dopamine Agonists [MoA], Dopaminergic Agonist
- Marketing category
- NDA
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request this medication
Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

